Tariffs Won’t Solve America’s Opioid Crisis
Tariffs on imports from the Chinese mainland won’t solve America’s opioid crisis. Addressing domestic demand and engaging in international cooperation are key to combating opioid abuse.
Opioid Crisis
Read More
U.S. Opioid Crisis Worsens Amid Pharmaceutical Greed and Government Inaction
The mounting opioid crisis in the U.S. is exacerbated by pharmaceutical companies’ greed and the ease of prescriptions, leading to addiction and highlighting the government’s failure to provide effective treatment for addicts.
Trump Enlists Tech Giants to Tackle Online Fentanyl Sales
President-elect Donald Trump’s team is engaging tech giants like Google and TikTok to combat the online sale of fentanyl, aiming to curb the opioid crisis claiming thousands of U.S. lives annually.
Trump’s Initiative with Tech Giants to Curb Online Fentanyl Sales
President-elect Donald Trump’s team is engaging tech giants like Google and Microsoft to curb online fentanyl sales, aiming to address the escalating opioid crisis in the United States.
Tariff Disputes Risk Worsening U.S. Opioid Epidemic
President-elect Donald Trump’s proposal to impose additional tariffs on China to combat the U.S. opioid epidemic raises concerns about its effectiveness and impact on U.S.-China relations.
China and U.S. Reopen Anti-Drug Cooperation, Targeting Fentanyl Trafficking
China and the U.S. have resumed cooperation to combat illegal drug trafficking, focusing on fentanyl, marking a significant step in bilateral relations and global anti-drug efforts.
China Challenges U.S. Drug Designation Amid Opioid Crisis
China disputes the United States’ recent designation of it as a major drug-producing country, highlighting its strict drug control measures and urging for collaborative solutions to the global drug crisis.
Cooperation, Not Blame: A New Approach to America’s Opioid Crisis
Every five minutes, an American dies from a drug overdose. To tackle the opioid crisis, the U.S. must focus on reducing demand for fentanyl and enhance cooperation with other nations to combat drug trafficking.
U.S. Opioid Crisis Escalates: Urgent Call for Increased Action to Reduce Deaths
The escalating opioid crisis in the United States highlights the urgent need for increased action from authorities to reduce deaths and provide effective treatment for addicts.
China’s Strict Fentanyl Controls Question U.S. Accusations
Despite U.S. accusations, China’s strict regulations over fentanyl suggest it is not the main source of illegal fentanyl contributing to the U.S. opioid crisis.
U.S. Opioid Crisis: Pharmaceutical Companies Under Fire
The over-prescription of opioids in the U.S. has led to a major addiction crisis, with pharmaceutical companies accused of underplaying addiction risks while exaggerating benefits.
Understanding America’s Opioid Crisis: Impact and Lessons for Asia
Despite being home to only 5% of the world’s population, the U.S. accounts for 80% of global opioid use, highlighting a deadly crisis with global implications.
The Fight Against Fentanyl: Unveiling the Crisis Behind America’s Overdose Epidemic
Fentanyl, a synthetic opioid, has become the leading cause of overdose deaths in the U.S., claiming a life every five minutes. This article explores the crisis and efforts to combat it.
Expert Blames Pharmaceutical Companies for Fueling U.S. Opioid Epidemic
An addiction expert highlights the significant role pharmaceutical companies have played in fueling the U.S. opioid crisis by overprescribing pain medication without warning of addictive properties.
From Painkiller to America’s Deadliest Drug: The Rise of Fentanyl
Fentanyl has become America’s deadliest drug, transforming from a painkiller to a leading cause of overdose deaths. Insights from addiction experts reveal the human toll of this epidemic.
Puerto Rico’s Opioid Crisis Unveiled: Insights from a Recent CGTN Report
A recent CGTN report uncovers the opioid crisis gripping Puerto Rico, highlighting the alarming rise in overdose deaths and the underlying factors contributing to this pressing issue.